GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday… [read more]
Blog
GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday… [read more]
/cdn.vox-cdn.com/uploads/chorus_asset/file/25410274/Clipboard_04_20_2024_01.jpg)
/cdn.vox-cdn.com/uploads/chorus_asset/file/24273495/226437_M_Huigen_year_in_crypto.jpg)
